Skip to content

IC Researchers on Front Line of COVID-19

Researchers at Beaumont Health System in Michigan working to develop the first objective diagnostic test for IC, have temporarily shifted gears to help address the COVID-19 pandemic, but will return to IC research later this year.

Dr. Michael Chancellor, Dr. Laura Lamb, and Sarah Bartolone shifted gears early this year to develop a rapid test for COVID-19 that can be interpreted by medical professionals without specialized training or equipment. The team plans to resume its Department of Defense-funded IC research, for which ICA will help crowdsource urine samples nationwide, in the fall. Read more about the Beaumont team’s work in the upcoming issue of ICA Update, and watch for updates on the IC research from ICA and at


Copyright 2019 Interstitial Cystitis Association – Privacy